Health authorities in England have identified a newly evolved variant of mpox, discovered in a patient who had recently travelled to Asia. Genome analysis revealed that the virus is a recombinant form, containing genetic material from both the more severe clade 1 and the milder clade 2 strain responsible for the 2022 global outbreak.
The UK Health Security Agency said it is still assessing how significant this new strain may be, noting that viral evolution is expected. While most mpox infections remain mild, officials urged those eligible to consider vaccination as a precaution.
Mpox, previously known as monkeypox, spreads through close physical contact with infected skin lesions, contaminated materials like bedding or clothing, or through respiratory droplets. Symptoms can take weeks to appear and often begin with fever, muscle aches and exhaustion, followed by a rash.
Experts say the emergence of a hybrid strain highlights the importance of continued genomic monitoring as mpox continues to circulate globally. The World Health Organization recorded nearly 48,000 cases and over 200 deaths this year across 94 countries.
If more infections with this variant appear, scientists will study how it transmits, whether illness could be more severe, and how well current vaccines respond — key factors in determining the risk it may pose.
